| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |